Overview

Metformin for the Treatment of Endometrial Hyperplasia

Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if metformin will be effective in making endometrial hyperplasia without atypia better by returning the tissue to a normal state.
Phase:
Early Phase 1
Details
Lead Sponsor:
UNC Lineberger Comprehensive Cancer Center
Treatments:
Metformin